Induction of hepatic apolipoprotein B mRNA editing for reducing serum cholesterol levels: a breakthrough or a disaster?
Greeve
J
J
Medizinische Klinik, Universitats-Krakenhaus Eppendorf, Hamburg, Germany.
Chowdhury
J R
JR
Chowdhury
N R
NR
D000071479:APOBEC-1 Deaminase; D000818:Animals; D030801:Animals, Genetically Modified; D001055:Apolipoproteins B / Q000378:metabolism*; D002784:Cholesterol / Q000097:blood*; D003564:Cytidine Deaminase / Q000378:metabolism*; D003641:Deamination; D008099:Liver / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D000098830:AICDA (Activation-Induced Cytidine Deaminase)
D001055:Apolipoproteins B; D012333:RNA, Messenger; D002784:Cholesterol; D000098830:AICDA (Activation-Induced Cytidine Deaminase); D000071479:APOBEC-1 Deaminase; D003564:Cytidine Deaminase